Depression by morphine and levorphanol of activity in sympathetic nerve fibres in anaesthetized rats

The effects of morphine administered into the vertebral artery on the somatosympathetic A- and C-reflexes in anesthetized cats

The effects of morphine (0.2-200 micrograms/kg) administered into the brain stem via a vertebral artery on the somatosympathetic A- and C-reflexes evoked in a cardiac sympathetic nerve by electrical stimulation of somatic myelinated (A) and unmyelinated (C) afferent nerve fibers in anesthetized cats were examined. The intravertebral arterial administration of 20-200 micrograms/kg morphine depressed dose-dependently both the somatosympathetic A- and C-reflexes. Following the administration of 200 micrograms/kg morphine, the amplitudes of the sympathetic A- and C-reflexes were depressed to 71 +/- 8% and 80 +/- 8% of the control magnitude, respectively. Injection of 2-200 micrograms/kg morphine caused hypotension in a dose-dependent manner. It is concluded that morphine administered in the brain stem via the vertebral artery produced a nonselective and slight depression of both the somatosympathetic A- and C-reflexes by acting at the level of brain stem.

Arterial catecholamine levels in morphine-treated rats subjected to sympathetic nerve stimulation

1. The effect of acute or chronic morphine treatment on the changes in arterial noradrenaline and adrenaline levels in response to sympathetic nerve stimulation was studied in rats. 2. Rats which had been chronically treated with morphine in their drinking fluid for 21 days were shown to be morphine-tolerant, as revealed by the tail-immersion test for analgesia. 3. It was found that animals given either acute or chronic morphine treatment had similar basal concentrations of arterial catecholamines to their controls. 4. Sympathetic nerve stimulation produced significant increases in arterial noradrenaline and adrenaline levels in both the control and morphine-treated animals. However, the degree of arterial noradrenaline elevation was significantly less in morphine-tolerant animals. 5. This phenomenon was not observed in acutely morphine-treated rats or at 2 weeks following opiate withdrawal in animals which had been treated previously with morphine for 3 weeks. 6. The findings suggest that chronic morphine treatment in rats not only leads to opiate tolerance but also reduces catecholamine release in response to sympathetic nerve stimulation.

Cardiovascular responses to sympathetic nerve stimulation in morphine-treated rats

The effects of morphine on the responses of blood pressure and pulse rate to stimulation of sympathetic nerves or to intravenous administration of noradrenaline were studied in female rats which had been treated with either an increasing concentration of morphine sulphate in their drinking fluid (5% sucrose solution), or an acute intraperitoneal injection of morphine. Sympathetic nerve excitation was effected by electrical stimulation of the thoracic segments of the spinal cord in pithed rats. Both sympathetic nerve stimulation and noradrenaline produced dose-dependent changes in blood pressure and pulse rate in naive rats and in the sucrose-drinking controls. Animals which had been chronically treated with morphine in their drinking fluid for 21 days showed significantly less intense responses to sympathetic nerve stimulation. However, these decreased responses were not observed in rats given acute treatment with morphine. Chronic treatment with morphine did not significantly influence the changes in blood pressure or pulse rate induced by noradrenaline. These findings suggest that chronic treatment with morphine lessens the cardiovascular responses to stimulation of peripheral sympathetic nerves in rats. The mechanism is not clear, but it seems unlikely to be due to changes in the sensitivity, or perhaps the number, of adrenoceptors.

Cardiac effects of thoracic epidural morphine caused by increased vagal activity in the dog

This study was carried out in order to investigate possible side-effects of thoracic epidural morphine on cardiac electrophysiology, haemodynamics and metabolism. In pentobarbital-anaesthetized dogs, intracardiac conduction times were determined by His bundle electrography, and refractoriness by programmed electrical stimulation; monophasic action potential recordings were obtained from the right ventricle by the suction electrode technique. Cardiac output, left ventricular and aortic blood pressures were measured, as well as plasma concentrations of morphine, free fatty acids, glycerol, glucose and lactate. Thoracic epidural morphine (0.12 mg X kg-1) reduced spontaneous heart rate, prolonged atrioventricular nodal conduction time and refractoriness, and reduced left ventricular dP/dt max. Bilateral vagotomy reversed these effects. Intra-atrial, His Purkinje and intraventricular conduction times, atrial and ventricular refractoriness and action potential duration, stroke volume and mean aortic blood pressure, as well as the metabolic variables, were not significantly influenced by thoracic epidural morphine with or without vagotomy. Peak plasma morphine levels of 12-25 ng X ml-1 were measured 10 min after morphine injection. In conclusion, this study demonstrates depressive side-effects of epidural morphine on cardiac function, mediated by an increased vagal activity.

Sensitivity of pulmonary chemo reflexes and lung inflation reflexes to repetitive stimulation and to inhibition with lidocaine and morphine

To study reflex responses caused by stimulation of pulmonary C-fibers and lung inflation, we used a preparation in which the left pulmonary artery and veins were ligated and cannulated and the right and left bronchi were cannulated separately in open-chest dogs. These experiments were performed to establish whether the reflex responses to injections of 150 micrograms of capsaicin through the left pulmonary circulation and inflations of this left lung to 30 cm H2O would be diminished if repeated frequently. Furthermore, the sensitivities of the reflex responses evoked by these capsaicin injections and by left lung inflations (LLI) to blockade with lidocaine or with morphine were studied. Both repeated injections of capsaicin into the left pulmonary circulation and repeated inflations of the left lung for up to 100 min produced a persistent triad of reflex responses: bradycardia, hypotension, and cessation of diaphragmatic contractions. Lidocaine injections (50 mg) into the pulmonary artery of the vascularly isolated lung abolished all reflex responses to subsequent injections of capsaicin, but only attenuated the triad of responses to subsequent left lung inflations by half. Morphine sulfate (60 mg) administered to the pulmonary vascular bed of the isolated lung reduced, but did not eliminate, the triad of reflex responses to subsequent capsaicin injections and lung inflations. The influences of morphine upon capsaicin and lung inflation responses were not abolished by naloxone.(ABSTRACT TRUNCATED AT 250 WORDS)

Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats

The influence of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity was determined in anaesthetized cats and rats. The effects of these drugs on blood pressure and heart rate were also evaluated. Impulse output was recorded in the splanchnic and vagus nerve of the cat, and in the cervical sympathetic trunk of the rat. Urapidil increased activity in sympathetic and parasympathetic nerve fibres in cats at low doses without affecting blood pressure and heart rate. At higher doses which lowered blood pressure, urapidil reduced sympathetic impulse output in cats and rats while vagal output was increased. The alpha 1-adrenoceptor blocking agent, prazosin, did not affect activity in sympathetic and parasympathetic nerve fibres while the beta-adrenoceptor blocking agent, propranolol, increased activity in these nerves in cats. The alpha-adrenoceptor agonist, clonidine, reduced sympathetic impulse output at all doses tested in both rats and cats. The results provide evidence that urapidil, in addition to its peripheral alpha- and beta-adrenoceptor blocking properties, affects cardiovascular regulation by a central action. Blockade of alpha- or beta-adrenoceptors in the brain is probably not responsible for the central effect of urapidil.